Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15917838 | 0.97 | — | — | |
| SCHEMBL15808924 | 0.93 | — | — | |
| SCHEMBL15808892 | 0.92 | — | — | |
| SCHEMBL15808847 | 0.91 | PDE4A (0.31) | — | |
| SCHEMBL15931795 | 0.89 | GPR84 (0.30) | — | |
| SCHEMBL14645915 | 0.89 | PDE4B (0.31) | — | |
| SCHEMBL20609994 | 0.88 | TDO2 (0.33) | — | |
| SCHEMBL29906286 | 0.88 | TDO2 (0.33) | — | |
| SCHEMBL14645919 | 0.88 | — | — | |
| SCHEMBL3736095 | 0.87 | PDE4B (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9630980-B2 | Asymmetrical ligands | BOREALIS AG (AT) | 2017-04-25 | — | — | US | claimed |
| US-20160024123-A1 | Asymmetrical Ligands | BOREALIS AG (AT) | 2016-01-28 | — | — | US | claimed |
| EP-2722345-B1 | CATALYST FOR THE POLYMERISATION OF OLEFINS | BOREALIS AG (AT) | 2018-12-05 | — | — | EP | disclosed |
| EP-2746289-B1 | Catalysts | BOREALIS AG (AT) | 2017-09-27 | — | — | EP | disclosed |
| EP-2729479-B1 | CATALYSTS | BOREALIS AG (AT) | 2017-09-06 | — | — | EP | disclosed |
| US-9630980-B2 | Asymmetrical ligands | BOREALIS AG (AT) | 2017-04-25 | — | — | US | disclosed |
| US-9630980-B2 | Asymmetrical ligands | BOREALIS AG (AT) | 2017-04-25 | — | — | US | disclosed |
| EP-2722344-B1 | POLYMERISATION PROCESS | BOREALIS AG (AT) | 2017-03-22 | — | — | EP | disclosed |
| US-9567351-B2 | Heterophasic copolymers | BOREALIS AG (AT) | 2017-02-14 | — | — | US | disclosed |
| US-9567351-B2 | Heterophasic copolymers | BOREALIS AG (AT) | 2017-02-14 | — | — | US | disclosed |
| US-9475890-B2 | Catalyst | BOREALIS AG (AT) | 2016-10-25 | — | — | US | disclosed |
| EP-2729479-A1 | CATALYSTS | Borealis AG (AT) | 2014-05-14 | — | — | EP | disclosed |
| EP-2729529-A1 | HETEROPHASIC COPOLYMERS | Borealis AG (AT) | 2014-05-14 | — | — | EP | disclosed |
| WO-2014060540-A1 | POLYMERISATION PROCESS AND CATALYST | BOREALIS AG (AT) | 2014-04-24 | — | — | WO | disclosed |
| WO-2014060541-A1 | POLYMERISATION PROCESS | BOREALIS AG (AT) | 2014-04-24 | — | — | WO | disclosed |
| EP-2722345-A1 | Catalyst | Borealis AG (AT) | 2014-04-23 | — | — | EP | disclosed |
| EP-2722344-A1 | Polymerisation process | Borealis AG (AT) | 2014-04-23 | — | — | EP | disclosed |
| EP-2722346-A1 | Polymerisation process and catalyst | Borealis AG (AT) | 2014-04-23 | — | — | EP | disclosed |
| WO-2013007664-A1 | HETEROPHASIC COPOLYMERS | BOREALIS AG (AT) | 2013-01-17 | — | — | WO | disclosed |
| WO-2013007650-A1 | CATALYSTS | BOREALIS AG (AT) | 2013-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024123-A1 | Asymmetrical Ligands | CCRL2, AR, CCR2 | ALDH1A1 2229/4885HIF1A 2134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.